Bhramara’s Prestigious Award for Distinguished Service to Humanity conferred on Covaxin-maker Mysore/Mysuru: Dr. Krishna Ella, Co-Founder and Executive Chairman of Bharat Biotech, Hyderabad, that invented Covaxin (the indigenous vaccine against COVID-19) has given a clarion call for the younger generation to take innovative steps so that a conducive atmosphere is created to check the next…
Dr. Krishna Ella stayed in Yadavagiri in Mysuru city during the 1980s. He was sent on Rotary Fellowship from Mysuru to study Master’s in the US which in a way contributed to the setting up of Bharat Biotech. Since Jan. 16, 2021, when India started administering the COVID-19 vaccine, there are several millions of people…
Dr. Krishna Ella, Co-Founder and Executive Chairman of Bharat Biotech, to receive the award in Mysuru on Mar. 4 Mysore/Mysuru: The science team of Bharat Biotech that developed the Covaxin vaccine has been selected to receive Bhramara’s Prestigious Award for Distinguished Service to Humanity instituted by the Bhramara Trust of Y.T. and Madhuri Thathachari, Mysuru….
Mysore/Mysuru: The Science team of Bharat Biotech that developed the Covaxin has been selected to receive Bhramara’s Prestigious Award for Distinguished Service to Humanity instituted by the Bhramara Trust of Y.T. and Madhuri Thathachari, Mysuru. “The Covaxin team of Bharat Biotech has made the whole country proud by developing this vaccine. Covaxin is the result…
Mysore/Mysuru: Bharat Biotech last week celebrated Covaxin’s Emergency Use Listing (EUL) by the World Health Organisation (WHO), two days after the global health organisation gave the much-anticipated nod to India’s indigenous vaccine. While celebrating the go-ahead given to the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech in partnership with ICMR and the National Institute of…
To be administered at JSS Hospital and Trauma Care Centre Mysore/Mysuru: As many as 11,200 doses of Covaxin, India’s indigenous COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV), has arrived in Mysuru last evening. It will be administered to citizens above…
Hyderabad: Covaxin, a vaccine candidate being developed by Bharat Biotech for COVID-19, can offer protection against mutations of Coronavirus, said Krishna Ella, Chairman and Managing Director of the city-based vaccine maker, on Tuesday. He also said the company had approached regulatory authorities seeking approval for an emergency license to use the vaccine, developed in collaboration…
Bharat Biotech Joint Managing Director says it may cost around Rs.300 per dose; Committed to distribute vaccine to ‘Bharat’ first Mysore/Mysuru: All know that Hyderabad-based Bharat Biotech is involved in developing Covaxin, a possible vaccine for the dreaded COVID-19 pandemic. But hardly a few know that two persons behind this company had stayed in ‘Namma…
Bengaluru: Stating that Covaxin trials will be successful in the State, Health and Medical Education Minister Dr. K. Sudhakar said Karnataka is fully prepared for the distribution of COVID-19 vaccine. He was speaking here after the launch of the 3rd phase clinical trials of Bharat Biotech’s Covaxin at Vydehi Institute of Medical Science and Research…
New Delhi: While Phase-1 human trials of Bharat Biotech’s Covaxin, India’s first indigenous COVID-19 vaccine candidate, are on at most of the 12 sites selected by Indian Council of Medical Research (ICMR) across the country, the Post-Graduate Institute of Medical Sciences (PGIMS), Rohtak, has claimed “encouraging” results from first part of tests. Earlier this week,…
Cheluvamba Hospital to get Mobile NICUFebruary 20, 2024
A first in India: Snake bite is a ‘notifiable...February 20, 2024
Heritage Tonga rally promotes awareness on Co...February 20, 2024
Modification of school motto triggers fiery d...February 20, 2024
Recent Comments